Literature DB >> 12607824

Melatonin, longevity and health in the aged: an assessment.

Russel J Reiter1, Dun-Xian Tan, Juan C Mayo, Rosa M Sainz, Silvia Lopez-Burillo.   

Abstract

This brief review considers the potential role of melatonin in the processes of aging, the prolongation of life span and health in the aged. Studies completed to date generally suggest that exogenously administered melatonin may serve to extend life span in invertebrates, but evidence supporting this conclusion in mammals is less compelling. Thus, any conclusion regarding a role for melatonin in extending normal longevity, particularly in mammals, would be premature. With regard to deferring the signs of chemically-induced neurodegenerative conditions in experimental animals, the data are remarkably strong and there is a modicum of evidence that in humans with debilitating diseases melatonin may have some beneficial actions. Indeed, this should be one focus of future research since as the number of elderly increases in the population, the frequency of costly age-related diseases will become increasingly burdensome to both the patient and to society as a whole.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12607824     DOI: 10.1080/1071576021000038504

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  12 in total

Review 1.  [Anti-aging. Facts and visions].

Authors:  N Y Schürer
Journal:  Hautarzt       Date:  2003-09       Impact factor: 0.751

Review 2.  Light, timing of biological rhythms, and chronodisruption in man.

Authors:  Thomas C Erren; Russel J Reiter; Claus Piekarski
Journal:  Naturwissenschaften       Date:  2003-10-14

3.  Increased melatonin levels in aqueous humor of patients with proliferative retinopathy in type 2 diabetes mellitus.

Authors:  Erdinc Aydin; Semsettin Sahin
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

Review 4.  Sirtuins, aging, and cardiovascular risks.

Authors:  Gaia Favero; Lorenzo Franceschetti; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  Age (Dordr)       Date:  2015-06-23

Review 5.  Melatonin, aging, and age-related diseases: perspectives for prevention, intervention, and therapy.

Authors:  Burkhard Poeggeler
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

6.  Aging and vascular dysfunction: beneficial melatonin effects.

Authors:  Luigi Fabrizio Rodella; Gaia Favero; Claudia Rossini; Eleonora Foglio; Francesca Bonomini; Russel J Reiter; Rita Rezzani
Journal:  Age (Dordr)       Date:  2011-11-23

Review 7.  Melatonin for the treatment of sepsis: the scientific rationale.

Authors:  Ruben Manuel Luciano Colunga Biancatelli; Max Berrill; Yassen H Mohammed; Paul E Marik
Journal:  J Thorac Dis       Date:  2020-02       Impact factor: 2.895

8.  Melatonin potentiates running wheel-induced neurogenesis in the dentate gyrus of adult C3H/HeN mice hippocampus.

Authors:  Jiabei Liu; Kathleen C Somera-Molina; Randall L Hudson; Margarita L Dubocovich
Journal:  J Pineal Res       Date:  2012-11-28       Impact factor: 13.007

9.  Regulation of L1 expression and retrotransposition by melatonin and its receptor: implications for cancer risk associated with light exposure at night.

Authors:  Dawn deHaro; Kristine J Kines; Mark Sokolowski; Robert T Dauchy; Vincent A Streva; Steven M Hill; John P Hanifin; George C Brainard; David E Blask; Victoria P Belancio
Journal:  Nucleic Acids Res       Date:  2014-06-09       Impact factor: 16.971

10.  Neuroprotective therapies after perinatal hypoxic-ischemic brain injury.

Authors:  Felipe Goñi de Cerio; Idoia Lara-Celador; Antonia Alvarez; Enrique Hilario
Journal:  Brain Sci       Date:  2013-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.